Development of a biodegradable alginate carrier system for antibiotics and bone cells

Journal of Orthopaedic Research

Volumn 25, Issue 1, 2007, Pages 62-72

  Ueng, Steve W N ^a   Lee, Mel S ^a   Lin, Song Shu ^a   Chan, Err Cheng ^b   Liu, Shih Jung ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Alginate; Biodegradable carrier; Infected bone defect; Mesenchymal stem cells; Vancomycin

Indexed keywords

ALGINIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; MESSENGER RNA; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BIODEGRADABILITY; BONE DEFECT; BONE DEVELOPMENT; BONE INFECTION; BONE MINERAL; CALCIUM METABOLISM; CELL CULTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE; TISSUE DIFFERENTIATION; TRABECULAR BONE;

ALGINATES; ALKALINE PHOSPHATASE; ANIMALS; ANTI-BACTERIAL AGENTS; BONE AND BONES; CALCIUM; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; MESENCHYMAL STEM CELL TRANSPLANTATION; ORGANIC CHEMICALS; OSTEOMYELITIS; OSTEOPONTIN; RABBITS; VANCOMYCIN;

EID: 33846084594     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20286     Document Type: Article

References (45)

1. Gustilo RB, Mendoza RM, Williams DN. 1984. Problems in the management of type III open fracture. J Trauma 24:742-746.
2. Askenasy N, Farkas DL. 2002. Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells 20:501-513.
3. Patzakis MJ, Kai M, Wilkin J, et al. 1993. Septopal beads and autogenous bone grafting for bone defects in patients with chronic osteomyelitis. Clin Orthop 295:112-118.
4. Ueng SWN, Wei FC, Shih CH. 1999. Management of femoral diaphyseal infected nonunion with antibiotic beads local therapy, external skeletal fixation and stage bone grafting. J Trauma 46:97-103.
5. Couch L, Cierny G, Mader JT. 1987. Inpatient and outpatient use of the Hickman catheter for adults with osteomyelitis. Clin Orthop 219:226-235.
6. Ueng SWN, Wei FC, Lee SS, et al. 1997. Management of large infected tibial defect with antibiotic beads local therapy and staged fibular osteoseptocutaneous free transfer. J Trauma 43:268-274.
7. Calhoun JH, Mader JT. 1997. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop 341:207-214.
8. Chun KH, Kwon IC, Kim YH, et al. 1996. Preparation of sodium alginate microspheres containing hydrophilic B-lactam Antibiotics. Arch Pharm Res 19:106-111.
9. Dacquet V, Varlet A, Tandogan RN, et al. 1992. Antibiotic-impregnated plaster of Paris beads. Clin Orthop 282:241-249.
10. Gordon CA, Hodges NA, Marriott C. 1988. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J Antimicrob Chemother 22:667-674.
11. Kirkpatrick DK, Trachtenberg LS, Mangino PD, et al. 1985. In vitro characteristics of tobramycin-polymethyl-methacrylate beads: Compressive strength and leaching. Orthopedics 8:1130-1133.
12. Dacquet V, Varlet A, Tandogan RN, et al. 1992. Antibiotic-impregnated plaster of Paris beads. Clin Orthop 282:241-249.
13. Lin SS, Ueng SWN, Liu SJ, et al. 1999. Development of a biodegradable antibiotic delivery system. Clin Orthop 362:240-250.
14. Ueng SWN, Yuan LJ, Lee N, et al. 2002. In vivo study of hot compressing molded 50:50 poly (DL-lactide-co-glycolide) antibiotic beads in rabbits. J Orthop Res 20:654-661.
15. Ueng SWN, Yuan LJ, Lee N, et al. 2004. In vivo study of biodegradable alginate antibiotic beads in rabbits. J Orthop Res 22:592-599.
16. Baltimore RS, Cross AS, Dobek AS. 1987. The inhibitory effect of sodium alginate on antibiotic activity against mucoid and non-mucoid strains of Pseudomonas aeruginosa. J Antimicrob Chemother 20:815-823.
17. Cappai A, Petruzzo P, Ruiu G, et al. 1995. Evaluation of new small barium alginate microcapsules. Int J Artif Organs 18:96-102.
18. Lin SS, Ueng SWN, Lee SS, et al. 1999. In Vitro Elution of Antibiotic from Antibiotic-Impregnated Biodegradable Calcium Alginate Wound Dressing. J. Trauma 47:136-141.
19. Ueng SWN, Lee SS, Lin SS, et al. 2000. Biodegradable alginate antibiotic beads. Clin Orthop 380:250-259.
20. Aydelotte MB, Thonar EJM, Mollenhauer J, et al. 1998. Culture of chondrocytes in alginate gel: Variations in conditions of gelation influence the structure of the alginate gel, and the arrangement and morphology of proliferating chondrocytes. In Vitro Cell Dev Biol Anim 34:123-130.
21. Downs EC, Robertson NE, Riss TL, et al. 1992. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol 152:422-429.
22. Esquisabel A, Hernandez RM, Igartua M, et al. 1997. Production of BCG alginate-PLL microcapsules by emulsification/internal gelation. J Microencapsul 14:627-638.
23. Joly A, Deshardins JF, Fremond B, et al. 1997. Survival proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. Transplant 63:795-803.
24. Lee KH, Lee PM, Siaw YS. 1993. Immobilization of aminoacylase by encapsulation in poly-l-lysin-stabilized calcium alginate beads. J Chem Tech Biotechnol 57:27-32.
25. Thu B, Bruheim P, Espevik T, et al. 1996. Alginate polycation microcapsules. Biomaterials 17:1031-1040.
26. Kapelle H, Ridder M. 1996. Analysis of Vancomycin in Serum. Chrompack Application Note 400-HPLC Application Book. Middulburg, Netherlands: Chrompack Inter BV Publication; p. 430.
27. Khalfi F, Deni T, Gressier B, et al. 1996. Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay. Int J Pharmaceutics 139:243-247.
28. Dennis JE, Haynesworth SE, Young RG, et al. 1992. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: Effect of fibronection and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1:23-32.
29. Komori T, Yagi H, Nomura S, et al. 1997. Targeted distribution of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
30. Rajamannan NM, Subramaniam M, Springett M, et al. 2002. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105:2660-2665.
31. Mader JT, Calhoun J, Cobos J. 1997. In vitro evolution of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads. Antimicrobi Agents Chemother 41:415-418.
32. Dell'Accio F, Vanlauwe J, Bellemans J, et al. 2003. Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J Orthop Res 21: 123-131.
33. Henry SL, Seligson D, Mangino P, et al. 1991. Antibiotic-impregnated beads. Part I: Bead implantation versus systemic therapy. Orthop Rev 20:242-247.
34. May JW, Jupiter JB, Weiland AJ, et al. 1989. Clinical classification of post-traumatic tibial osteomyelitis. J Bone Joint Surg (Am) 71A:1422-1428.
35. Buchholz HW, Engelbrecht H. 1970. Uber die depotwirkung einiger antibiotica bei vermischung mit dem kunstharz palacos. Chirurg 11:511-515.
36. Paham GJ, Mangino P, Seligson D, et al. 1991. Antibiotic-impregnated beads. Part II: Factors in antibiotics. Orthop Rev 20:331-337.
37. Majid SA, Lindberg LT, Gunterberg B, et al. 1985. Gentamycin-PMMA beads in the treatment of chronic osteomyelitis. Acta Orthop Scand 56:265-268.
38. Bruder SP, Fox BS. 1999. Tissue engineering of bone. Clin Orthop 3675:66-83.
39. Bruder SP, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive cultivation and following cryopreservation. J Cell Biochem 64:278-294.
40. Lennon DP, Haynesworth SE, Bruder SP, et al. 1996. Development of a serum screen for mesenchymal progenitor cells from bone marrow. In Vitro Cell Dev Biol 32:602-611.
41. Nakahara H, Bruder SP, Goldberg VM, et al. 1990. In vivo Osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop 259:223-232.
42. Pittenger MF, Mackay AM, Beck SC. 1999. Multilineage potential of adult human mensenchymal stem cells. Science 284:143-147.
43. Beresford JN. 1989. Osteogenic stem cells and stromal system of bone and marrow. Clin Orthop 240:270-280.
44. Kadiyala S, Young RG, Thiede MA, et al. 1997. Culture-Expander canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6:125-134.
45. Maniatopoulos C, Sodek J, Melcher AH. 1988. Bone formation in vitro by stromal cells obtained from marrow of young adult rats. Cell Tissue Res 254:317-330.